Clinical data
ATC code N07XX01 (WHO)
Synonyms (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
CAS Number 110101-66-1 N
PubChem (CID) 104903
ChemSpider 94673 YesY
UNII YD064E883I YesY
KEGG D08606 YesY
Chemical and physical data
Formula C38H52N6O2
Molar mass 624.859 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Tirilazad is a drug that has been proposed to treat acute ischaemic stroke. When tested on animal models, tirilazad protects brain tissue, and reduces brain damage. However, the drug fails to treat, and even worsens a stroke when studied on a human being.[1]

Usage in treatment of stroke

Tirilazad currently has no usage in the clinical treatment of stroke.


This article is issued from Wikipedia - version of the 8/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.